World's Best Scientists 2026 revealed!
Enrico Heffler

Enrico Heffler

D-Index & Metrics

Immunology

D-Index
58
Citations
12563
World Ranking
3513
National Ranking
137

Overview

Enrico Heffler is affiliated with Humanitas University in Italy and has made substantial contributions to medical research, particularly in the fields of physiology, pulmonary and respiratory medicine, immunology and allergy, otorhinolaryngology, and surgery. Their research portfolio includes 554 publications concentrated across these domains, reflecting a broad engagement with topics related to respiratory health and diseases.

The scientist's work focuses extensively on areas such as asthma and respiratory diseases, allergic rhinitis and sensitization, sinusitis and nasal conditions, respiratory and cough-related research, inhalation and respiratory drug delivery, chronic obstructive pulmonary disease (COPD) research, and nasal surgery and airway studies.

Frequent publication venues for their work include:

  • Allergy
  • World Allergy Organization Journal
  • Current Opinion in Allergy and Clinical Immunology
  • The Journal of Allergy and Clinical Immunology In Practice
  • Zenodo (CERN European Organization for Nuclear Research)

Notable recent papers authored or co-authored by Enrico Heffler are:

  • Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial, 2021, Journal of Allergy and Clinical Immunology
  • Eosinophilic and Noneosinophilic Asthma, 2021, CHEST Journal
  • EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023, 2023, Rhinology Journal
  • Biologics and airway remodeling in severe asthma, 2022, Allergy
  • Defining a Severe Asthma Super-Responder: Findings from a Delphi Process, 2021, The Journal of Allergy and Clinical Immunology In Practice

Enrico Heffler frequently collaborates with other researchers. Their most common co-authors include:

  • Giorgio Walter Canonica
  • Giovanni Paoletti
  • Francesca Puggioni
  • Luca Malvezzi
  • Gianenrico Senna

Best Publications

  • EUFOREA consensus on biologics for CRSwNP with or without asthma

    Wytske J. Fokkens;Valerie Lund;Claus Bachert;Claus Bachert;Joaquim Mullol

  • Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper.

    Marek L. Kowalski;Ioana Agache;Sevim Bavbek;Arzu Bakirtas

  • Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry.

    Eileen Wang;Michael E. Wechsler;Trung N. Tran;Liam G. Heaney

  • Interleukin-5 in the Pathophysiology of Severe Asthma

    Corrado Pelaia;Giovanni Paoletti;Francesca Puggioni;Francesca Racca

  • EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023.

    Unknown

  • Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial.

    Claus Bachert;Joseph K. Han;Martin Y. Desrosiers;Philippe Gevaert

  • Research needs in allergy: an EAACI position paper, in collaboration with EFA

    Nikolaos G Papadopoulos;Ioana Agache;Sevim Bavbek;Beatrice M Bilo

  • Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.

    Liam G. Heaney;Luis Perez de Llano;Mona Al-Ahmad;Vibeke Backer

  • Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.

    François-Xavier Lescure;Hitoshi Honda;Robert A Fowler;Jennifer Sloane Lazar

  • Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs

    Gilda Varricchi;Diego Bagnasco;Francesco Borriello;Enrico Heffler

  • Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma

    Enrico Heffler;Lorena Nascimento Girardi Madeira;Matteo Ferrando;Francesca Puggioni

  • Biologics and airway remodeling in severe asthma

    Unknown

  • Causes of food-induced anaphylaxis in Italian adults: a multi-centre study.

    R. Asero;L. Antonicelli;A. Arena;L. Bommarito

  • Toward clinically applicable biomarkers for asthma: An EAACI position paper.

    Zuzana Diamant;Zuzana Diamant;Susanne Vijverberg;Kjell Alving;Arzu Bakirtas

  • The Severe Asthma Network in Italy: Findings and Perspectives.

    Enrico Heffler;Francesco Blasi;Francesco Blasi;Manuela Latorre;Francesco Menzella

  • EpidemAAITO: features of food allergy in Italian adults attending allergy clinics: a multi-centre study.

    R. Asero;L. Antonicelli;A. Arena;L. Bommarito

  • The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma

    Giancarlo Marone;Francescopaolo Granata;Valentina Pucino;Antonio Pecoraro

  • Allergy in severe asthma

    S R Del Giacco;A Bakirtas;E Bel;A Custovic

  • Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets

    Unknown

  • Defining a Severe Asthma Super-Responder: Findings from a Delphi Process.

    John W. Upham;John W. Upham;Chantal Le Lievre;David J. Jackson;Matthew Masoli

  • Minimal clinically important difference for asthma endpoints: An expert consensus report

    Matteo Bonini;Matteo Bonini;Marcello Di Paolo;Diego Bagnasco;Ilaria Baiardini

  • Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry.

    Giorgio Walter Canonica;Giorgio Lorenzo Colombo;Giacomo Matteo Bruno;Sergio Di Matteo

  • Extended IgE profile based on an allergen macroarray: a novel tool for precision medicine in allergy diagnosis

    Enrico Heffler;Francesca Puggioni;Silvia Peveri;Marcello Montagni

  • Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders

    Gilda Varricchi;Diego Bagnasco;Francesco Borriello;Enrico Heffler

Frequent Co-Authors

Giovanni Rolla
Giovanni Rolla University of Turin
Giorgio Walter Canonica
Giorgio Walter Canonica Humanitas University
Francesco Blasi
Francesco Blasi University of Milan
Giovanni Passalacqua
Giovanni Passalacqua University of Genoa
Pierluigi Paggiaro
Pierluigi Paggiaro University of Pisa
Gianenrico Senna
Gianenrico Senna University of Verona
Nikolaos G. Papadopoulos
Nikolaos G. Papadopoulos National and Kapodistrian University of Athens
Claus Bachert
Claus Bachert Karolinska Institute
Liam G. Heaney
Liam G. Heaney Queen's University Belfast
David Price
David Price University of Aberdeen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open doors to diverse healthcare career paths. For example, transitioning to roles like an acute care nurse practitioner becomes accessible through acute care np certification, which equips nurses with specialized skills to manage critically ill patients.

Many professionals accelerate their journey through healthcare by enrolling in an accelerated nurse practitioner program. These programs offer a faster pathway to advanced practice roles, ideal for those aiming to quickly enter the workforce with advanced credentials.

For individuals without a nursing background, there are excellent options like 12-month accelerated nursing programs online for non nurses. These programs provide a rapid and flexible route into nursing, making the transition smoother and more accessible.

Lastly, some prospective students benefit from exploring absn programs with high acceptance rates. These programs increase the chances of admission, helping students begin their nursing education without prolonged delays.

Best Scientists Citing Enrico Heffler

Trending Scientists

Recently Published Articles